tiprankstipranks
Advertisement
Advertisement

GDRX Stock Latest News

GoodRx price target raised to $4.50 from $3.50 at Raymond James
The FlyGoodRx price target raised to $4.50 from $3.50 at Raymond James
15h ago
GDRX
GoodRx price target raised to $4 from $3 at Morgan Stanley
PremiumThe Fly
GoodRx price target raised to $4 from $3 at Morgan Stanley
15h ago
GDRX
GoodRx price target raised to $4 from $3.50 at Goldman Sachs
PremiumThe Fly
GoodRx price target raised to $4 from $3.50 at Goldman Sachs
18h ago
GDRX
GoodRx price target raised to $5 from $3.50 at Leerink
PremiumThe Fly
GoodRx price target raised to $5 from $3.50 at Leerink
1d ago
GDRX
GoodRx reports Q2 adjusted EPS 8c, consensus 8c
PremiumThe Fly
GoodRx reports Q2 adjusted EPS 8c, consensus 8c
2d ago
GDRX
GoodRx raises FYF26 revenue view to $790M-$805M from $765M-$785M
PremiumThe FlyGoodRx raises FYF26 revenue view to $790M-$805M from $765M-$785M
2d ago
GDRX
Citi adds ‘upside 30-day catalyst watch’ on GoodRx
Premium
The Fly
Citi adds ‘upside 30-day catalyst watch’ on GoodRx
16d ago
GDRX
GoodRx Stockholders Approve Directors, Auditor and Executive Pay
Premium
Company Announcements
GoodRx Stockholders Approve Directors, Auditor and Executive Pay
2M ago
8K
GDRX
AI Models Split on GoodRx (GDRX) as Turnaround Meets Revenue Headwinds
PremiumAI Analyst Ratings
AI Models Split on GoodRx (GDRX) as Turnaround Meets Revenue Headwinds
2M ago
GDRX
GoodRx launches GoodRX Companion, a new subscription
PremiumThe Fly
GoodRx launches GoodRX Companion, a new subscription
2M ago
GDRX
AI Models Split on GoodRx: Quality Turnaround vs. Revenue Risks in Focus
PremiumAI Analyst Ratings
AI Models Split on GoodRx: Quality Turnaround vs. Revenue Risks in Focus
3M ago
GDRX
Trump Trade: Trump announces expansion of TrumpRx.gov
PremiumThe Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
3M ago
AZN
BMY
AI Models Diverge on GoodRx as Technical Momentum Meets Legacy Headwinds
PremiumAI Analyst RatingsAI Models Diverge on GoodRx as Technical Momentum Meets Legacy Headwinds
3M ago
GDRX
AI Models Split on GoodRx: Momentum vs. Revenue Risk in Focus
Premium
AI Analyst Ratings
AI Models Split on GoodRx: Momentum vs. Revenue Risk in Focus
3M ago
GDRX
GoodRx price target raised to $4 from $3.50 at Citi
Premium
The Fly
GoodRx price target raised to $4 from $3.50 at Citi
3M ago
GDRX
GoodRx price target raised to $4 from $3 at TD Cowen
PremiumThe Fly
GoodRx price target raised to $4 from $3 at TD Cowen
3M ago
GDRX
Analyst Maintains Buy on GoodRx as High-Value Segments Gain Traction; Price Target Kept at $3.50
PremiumRatings
Analyst Maintains Buy on GoodRx as High-Value Segments Gain Traction; Price Target Kept at $3.50
3M ago
GDRX
GoodRx Earnings Call Highlights Pharma Direct Momentum
PremiumCompany Announcements
GoodRx Earnings Call Highlights Pharma Direct Momentum
3M ago
GDRX
GoodRx price target raised to $3.50 from $2.50 at Goldman Sachs
PremiumThe Fly
GoodRx price target raised to $3.50 from $2.50 at Goldman Sachs
3M ago
GDRX
Notable companies reporting after market close
PremiumThe FlyNotable companies reporting after market close
3M ago
Z
ZG
GoodRx reports Q1 adjusted EPS 7c, consensus 7c
Premium
The Fly
GoodRx reports Q1 adjusted EPS 7c, consensus 7c
3M ago
GDRX
GoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
Premium
The Fly
GoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
3M ago
GDRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >